Skip to content
healthcare.dev

LUMO Booz Hangover Companiion

NDC 81425-003, Chininum arsenicosum, Natrum phosphoricum, Nux voomica, Vespa crabro, tablet, chewable, from Applied Bioenergetics, LLC.

Product NDC
81425-003
Status
Listed
Labeler
Applied Bioenergetics, LLC
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81425-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • QUININE ARSENITE30 [hp_C]/1
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE30 [hp_C]/1
  • STRYCHNOS NUX-VOMICA SEED30 [hp_C]/1
  • VESPA CRABRO30 [hp_C]/1

Pharmacologic classes

Allergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]

Package NDCNDC-11Package
81425-003-1081425000310180 TABLET, CHEWABLE in 1 BOTTLE (81425-003-10)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 81425-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81425-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81425-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.